PubMed HealthSearch

Biomedical subjects

A F Mitchenko

Publications and source records attributed to A F Mitchenko.

7 recordsLinked to original sources

[Elaboration of clinico-laboratory criteria of the Mycoplasma variants of rheumatoid arthritis in children].

To develop clinical and laboratory criteria for the differential diagnosis of Mycoplasma-induced arthritides in 78 children with documented rheumatic arthritis (RA), a comprehensive study involving microbiological, immunological, and clinical tools has been performed. Some specific signs of the clinical course of Mycoplasma-induced RA have been defined. However, a differential diagnosis of Mycoplasma-induced arthritis may be made on the basis of a comprehensive study of a patient.

Adolescent

[Yersinia arthritis in children].

Clinical and laboratory evaluation of arthritis in 36 children with diagnosed enteric yersiniosis is presented on seven-years' follow-up data. Twenty-eight patients were found to have an active course of the disease developing in cycles with a favourable outcome and no residual effects. In eight cases arthritis took a protracted (up to 8-10 months) or chronic (over 12 months) course which ended in clinical and laboratory remission; in three of the eight cases the clinical picture was similar to that of rheumatoid arthritis, in two of which the diagnosis was not excluded by the morphological study of the synovial biopsy sample.

Arthritis, Infectious

[Mycoplasma and rheumatoid arthritis in children].

A microbiological and serologic investigation was carried out in 80 children with rheumatoid arthritis (RA) in order to detect Mycoplasma and Ureaplasma as possible causative agents of RA. The antigen of Mycoplasma in question is shown to be detectable in 42.6% of cases more commonly as part of an association of 2 or more species. M. arthritidis and U. urealyticum are the more common findings. Anti-mycoplasma antibodies were detected in 25.7% of the examined children. The role of these Mycoplasma species in RA is discussed, as is the need for etiotropic treatment of mycoplasma rheumatoid arthritis.

Arthritis, Rheumatoid